Today’s newsletter takes about 5 minutes to read—so if you’ve only got 60 seconds, here’s what you need to know:

🥼 At Webdelics, we’re closely paying attention to the therapies that challenge the limits of conventional care… And asking the questions that come with them.

As interest in ibogaine grows, so does the need for clear thinking around evidence, ethics, access, and what meaningful recovery can really look like.

👋 New here? We do this every week… Join Us!

🧠 Dr. Jeff McNairy, Chief Medical Officer at Rythmia, the world’s first medically licensed ayahuasca retreat.

With over 18,000 reported transformations, Rythmia is at the forefront of integrating plant medicine into modern healing.

📅 Thursday, April 23, 2026 (Virtual Event)
🕔 5 PM PST / 7 PM CST / 8 PM EST

👉 Register Here

❓ Anonymous Questions? Submit Them Here!

🎧 In this episode, we sit down with Ross Sullivan to explore how psychedelics may influence not just personal healing, but broader social changes in society. With a background in holistic health and sustainability, Ross offers a thoughtful perspective on connection, culture, and collective well-being.

⚡️ Tune in for an enlightening conversation on consciousness, intentionality, and what it could look like to bring psychedelics into society with care…

For decades, traumatic brain injury (TBI) has been one of the hardest conditions to treat, especially for veterans living with both visible and invisible wounds.

Sadly, many chronic TBI patients struggle with persistent symptoms of PTSD, depression, anxiety, poor concentration, memory problems, and reduced daily functioning long after service.

Existing treatments can help some, but many are still left searching for better options…

Which is precisely why ibogaine is such an interesting topic of interest.

In 2024, Stanford researchers published a landmark prospective observational study of 30 U.S. Special Operations veterans with a history of repeated blast exposure and predominantly mild TBI who received magnesium-ibogaine therapy in Mexico, where treatment was legally available.

Because the study was observational and did not include a control group, it cannot prove causation, but the results were striking…

Within one month, participants showed:

And more importantly, these findings helped put ibogaine on the map as a serious area of investigation for veterans with complex trauma and brain injury.

Fortunately, the Stanford paper is no longer the only publication out there that has investigated ibogaine for treating TBI’s and head injuries…

A later PubMed-indexed follow-up reported functional neuroimaging findings from this veteran cohort, suggesting measurable brain-level changes accompanying the clinical improvements that were reported.

And another follow up paper examined the subjective or mystical-type experiences reported during the magnesium-ibogaine treatments, once again providing evidence for why these patients saw the improvements they did. There’s also a published clinical review that provides clinicians an updated playbook for ibogaine’s potential risks, monitoring needs, and therapeutic rationale as well.

Together, these papers collectively suggest that ibogaine may be an emerging treatment for TBI’s and complex neurological trauma, but as you can imagine, more studies are needed to truly understand what’s going on.

Researchers think ibogaine may work through several pathways at once…

Preclinical and literature reviews suggests it may affect neuroplasticity-related signaling within the brain, increasing the production of fertilized-like neuronal compounds like Brain-Derived Neurotrophic Factor (BDNF) and Glial cell Derived Neurotrophic Factor (GDNF), while simultaneously interacting with serotonin, dopamine, glutamate, and opioid-related systems.

Collectively, these mechanisms make ibogaine a biologically plausible treatment that could affect mood, trauma symptoms, and even cognition…

But with what the data shows and what we know today, it’s still more accurate to say ibogaine “may support recovery” than to claim it definitively “heals the brain.”

Nuance matters in this context…

As one can imagine, taking ibogaine is not risk-free, for multiple reasons.

First, the biggest concern with iboga is cardiac safety, especially QT prolongation and dangerous arrhythmias of the heart, which is why rigorous screening and medical supervision is imperative, especially in clinical trials.

In the Stanford veteran cohort, magnesium was intentionally included in the protocol as an added protection for these mechanisms, and while there were no serious unexpected treatment-emergent adverse events reported, it shouldn’t be mistaken for proof that the treatment is broadly safe in all settings.

Consuming iboga is VERY different (and a completely different experience) than taking mushrooms with your friends at a concert…

Thanks to some groundbreaking efforts by activists and veteran support groups, ibogaine is quickly moving beyond academic discussions and into state policy.

Former Texas Gov. Rick Perry has become one of the most visible advocates for ibogaine access for veterans, and in 2025 Texas governor Greg Abbott enacted SB 2308, a law designed to support FDA-oriented ibogaine drug-development trials.

The Texas Tribune reported the initiative as a $50 million state investment, and the governor’s office said the law was intended to help evaluate ibogaine for conditions affecting veterans, including neurological and behavioral health conditions.

The early evidence is promising, and with continued research efforts and legislative changes, we could see some exciting developments occur supporting ibogaine and it’s use in clinical settings.

And with even more research underway, it’s safe to say that ibogaine has officially moved from the margins of psychedelics into serious scientific and political conversations, especially around veterans with TBI, PTSD, and trauma-related suffering…

What happens next will depend on larger controlled trials, continued safety oversight, and careful regulation.

And we will be sure bring it all to you when it happens!

Note: Ibogaine should only be used in a legal setting under trained medical supervision.

Healing rarely moves in a straight line…

In a space as complex as psychedelics, it is easy to get swept up in bold claims or breakthrough headlines.

But real progress asks us to hold space for two things at once: hope for what may be possible, and responsibility in how we approach it.

Hopefully, that’s why you’re here…

At Webdelics, we’re here to make plant-medicine and psychedelic education clear, evidence-based, and actionable, so you can make informed choices and finally have the knowledge to ask the questions to get the answers you’re truly looking for.

📩 If this helped, forward it to someone who feels stuck in their life and is asking for more…

💬 Questions, corrections, or topics to cover next? Hit reply.

🪧 Want to sponsor? [email protected]